Acne Drugs Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS25012202 | Research Suite: Report (PDF) & Market Data (Excel)
The global acne drugs market is estimated to be valued at USD 13.4 billion in 2024, and a CAGR of 5.3% is expected during the forecast period. Acne is a skin condition that arises when hair follicles get clogged with dead skin cells and oil. This disease is very common in teenagers, although people of all age groups are affected by it.
Increasing prevalence of skin disorders and increasing clinical approval of drugs are driving growth in the market. Globally the prevalence of skin conditions has increased. Launching novel drugs and high efficiency of treatment of acne propels the market growth significantly. Rising incidence of acne conditions among adults is the key factor behind the significant growth in the market.
Growth
Drivers
Rising disposable income, especially in emerging economies, has enabled more people to invest in skincare and healthcare products. Increasing emphasis on skincare and aesthetic appearance is leading more people to consult doctors and take medical advice and treatments for acne. Ongoing research and development have led to the introduction of novel acne treatments, including biologics and combination therapies. These advancements offer improved efficacy.
Modern lifestyle choices, such as unhealthy diets, high stress levels, and exposure to pollution, are the factors responsible for significant growth in the market. Acne is the most common skin problem, and it is affecting more than 9% of the world’s population. High prevalence of acne disease demands for the acne drugs, which act efficiently to treat the acne disease.
Rising
healthcare expenditure, and increasing awareness among the people about early
diagnosis, and treatment of diseases is driving growth in the market. Rising
emphasis on beauty and wellness is the key reason behind the significant growth
in the most part of world, and witnessing significant growth during the
forecast period.
Segmentation
By
Route of Administration
·
Oral
·
Topical
By
Distribution Channel
·
Hospital Pharmacies
·
Retail Pharmacies
·
Online Pharmacies
By
Products
·
Retinoids
·
Antibiotics
·
Isotretinoin
·
Others
By
Age-Group
·
Teenagers
·
Adult people
·
Geriatric people
Regional
Outlook
·
Asia Pacific
·
North America
·
Latin America
·
Middle East and Africa
·
Europe
Acne
Drugs Market by Route of Administration Segmentation
On the basis of the route of administration, The Acne Drugs Market is segmented into Oral, and Topical. Increasing number of companies manufacturing topical solutions for Acne treatment. This is attributed to the patient population suffering from the condition, which is primarily intrigued by topical solutions as these products are easily available and comfortable.
Rising
number of patients suffering from skin diseases need treatment, and they are
driving the market growth significantly. Oral segment is also expected to
contribute during the forecast period due to an increase in condition’s
prevalence, and the growing number of product launches. Taking medicine orally
is the most common, and traditional method, and is expected to dominate the
market due to easiness and efficacy during the forecast period. Rising
healthcare expenditure is growing the demand for better skincare in the market.
Acne
Drugs Market by Distribution Channel Segmentation
On the basis of the distribution channel, the acne drugs
market is segmented into hospital pharmacies, retail pharmacies, and online
pharmacies. Hospital pharmacy is the leading segment in the market due to the
increasing prevalence of skin disorders and the increasing number of patient
flows in the hospitals. Hospitals are well equipped and widely accessible for
the patients due to the increasing number of skin patients and rising demand
for skincare.
The retail and online pharmacies are expected to witness
lucrative growth during the forecast period due to increasing number of online
portals, and websites commercializing acne treatment products. Increasing
growth in E-commerce, which had made it more convenient for users to purchase
the products efficiently. Increasing pollution in all over the world is acting
like a catalyst for the growth in this market.
Regional
Outlook
On the basis of the regions, the acne drugs market is segmented into 5 regions: Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. North America is the leading market due to rising concern about beauty and wellness among the people. Rising disposable income and increasing consciousness among people are the key factors driving growth in the market significantly. Increasing awareness regarding the advanced treatments and the presence of major brands are the key reasons behind the growth in the market. Europe is the second fastest-growing region in the market.
The increasing number of young adults and teenagers in the region is the key factor behind the significant growth in the market. The United Kingdom is the fastest-growing market in the region, where more than 90% of people in the age group 11-30 are suffering from acne to some extent. Various organizations in the region promoting awareness about the skincare are driving growth in the region significantly. Though the pandemic had an adverse effect on the market in Europe, the European region is one of the fastest-growing regions during the forecast in the market.
Asia Pacific is also witnessing significant growth due to increasing population and rising disposable income in the emerging economies like China and India. The adoption of advanced technologies and data-driven approaches is enabling personalized acne treatment plans. Utilizing artificial intelligence and machine learning, healthcare providers are developing tailored treatments based on individuals’ skin conditions and genetic factors. The region is attracting significant investment in the acne treatment market, indicating a growing market for advanced acne treatment technologies in the region.
Increased consumer spending on skincare
is the key factor behind the significant growth in the Asia Pacific region,
including India, China, and South Korea. Driven by technological advancements
and rising growth in the e-commerce sector, the region is witnessing
significant growth in the market. Increasing consumer demand for effective acne
solutions is driving the market towards significant success. Middle East and
Africa, and Latin America is also witnessing significant growth during the
forecast period due to rising prevalence of disease, and increasing demand for
the effective treatment.
Key
Players
· ABBVIE INC.
·
Botanix Pharmaceuticals
·
GALDERMA
·
Bausch Health Companies Inc.
·
Bayer AG
·
Johnson & Johnson Services, Inc.
·
Teva Pharmaceutical Industries Ltd.
· Other Players